FRIDAY, Dec. 13, 2024 -- Omission of surgical axillary staging is noninferior to sentinel-lymph-node biopsy for patients with clinically...

Patients with early-stage, node-negative, hormone receptor (HR)-positive, HER2- negative breast cancer who have a high risk of recurrence based on the...

THURSDAY, Dec. 12, 2024 -- For patients with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast...

MONDAY, Dec. 16, 2024 -- Risk-reducing mastectomy (RRM) and salpingo-oophorectomy (RRSO) are both associated with significant improvements in outcomes...

MONDAY, Dec. 9, 2024 -- Five-year breast cancer (BC) risk prediction is improved with the addition of previous screening mammogram images beyond...

MONDAY, Dec. 9, 2024 -- Five-year breast cancer (BC) risk prediction is improved with the addition of previous screening mammogram images beyond...

Recent results from the Phase III NRG-RTOG 1112 clinical study showed that the addition of stereotactic body radiotherapy (SBRT) to systemic therapy...

A machine learning (ML) model incorporating both clinical and genomic factors outperformed models based solely on either clinical or genomic data in...

FRIDAY, Dec. 20, 2024 -- For patients with advanced breast cancer and baseline clinical anxiety, cannabidiol (CBD) is safe and may reduce anxiety...

FRIDAY, Dec. 20, 2024 -- For patients with advanced breast cancer and baseline clinical anxiety, cannabidiol (CBD) is safe and may reduce anxiety...